بدائل البحث:
largest decrease » larger decrease (توسيع البحث), marked decrease (توسيع البحث)
less decrease » teer decrease (توسيع البحث), we decrease (توسيع البحث), levels decreased (توسيع البحث)
nn decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), gy decreased (توسيع البحث)
largest decrease » larger decrease (توسيع البحث), marked decrease (توسيع البحث)
less decrease » teer decrease (توسيع البحث), we decrease (توسيع البحث), levels decreased (توسيع البحث)
nn decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), gy decreased (توسيع البحث)
-
1781
-
1782
-
1783
-
1784
-
1785
-
1786
-
1787
-
1788
-
1789
-
1790
-
1791
-
1792
-
1793
-
1794
Study data.
منشور في 2025"…</p><p> Conclusion </p><p>During the COVID-19 pandemic, both roxadustat and ESAs effectively improved renal anemia in PD patients, however, the roxadustat group experienced less additional costs for anemia correction and better medication compliance.…"
-
1795
Summary of clinical outcomes after 9 months.
منشور في 2025"…</p><p> Conclusion </p><p>During the COVID-19 pandemic, both roxadustat and ESAs effectively improved renal anemia in PD patients, however, the roxadustat group experienced less additional costs for anemia correction and better medication compliance.…"
-
1796
Approval by the research ethics committee.
منشور في 2025"…</p><p> Conclusion </p><p>During the COVID-19 pandemic, both roxadustat and ESAs effectively improved renal anemia in PD patients, however, the roxadustat group experienced less additional costs for anemia correction and better medication compliance.…"
-
1797
-
1798
-
1799
Risk Illustration.
منشور في 2025"…Similarly, patients with EF > 40% had decreased incidence of SCD compared to those with EF < 40% (HR 0.347, 95% CI:0.158–0.763; p = 0.008). …"
-
1800
Predictors of SCD.
منشور في 2025"…Similarly, patients with EF > 40% had decreased incidence of SCD compared to those with EF < 40% (HR 0.347, 95% CI:0.158–0.763; p = 0.008). …"